HHS.gov - 30 Jan 2024
The Biden-Harris Administration announced today that sickle cell disease (SCD) will be the first focus of the Cell and Gene Therapy (CGT) Access Model.
NHS England - 14 Feb 2024
NHS England — North East and Yorkshire » Sickle cell patients in North East to benefit from national £1.5m technology ... ...
Manchester University NHS Foundation Trust - 05 Mar 2024
Country's first specialist unit launches in Manchester to support patients with sickle cell disease ...
European Medicines Agency | - 15 Dec 2023
First gene editing therapy to treat beta thalassemia and severe sickle cell disease | European Medicines Agency ...
Manchester University NHS Foundation Trust - 15 Jan 2024
Sickle Cell Children & Young Person's Peer Mentoring Programme for Manchester, Liverpool and Sheffield (North West ... ...